Search research articles
Contact Us
Filters
Showing results (251-260 of 342) with videos related to
Page
of 35
Sort By:
Urologic Oncology
|
February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective study
Emily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.
Oncotarget
|
March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
Markus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Urologic Oncology
|
October 23, 2022
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria
Eva Charlotte Kuckuck, Jörg Hennenlotter, Tilman Todenhöfer, et al.
Urologic Oncology
|
February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer
Natalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
Frontiers in Oncology
|
December 16, 2021
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)
Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, et al.
BJU International
|
January 14, 2010
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
Christian Bolenz, Edwin Herrmann, Patrick J Bastian, et al.
World Journal of Urology
|
August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series
Sabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
International Journal of Surgical Pathology
|
April 25, 2022
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
European Urology
|
January 15, 2010
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study
Giacomo Novara, Kazumasa Matsumoto, Wassim Kassouf, et al.
World Journal of Urology
|
January 21, 2011
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients
Wolfgang Otto, Shahrokh F Shariat, Hans-Martin Fritsche, et al.
Page
of 35
Search research articles
Search
Showing results (251-260 of 342) with videos related to
Sort By:
Page
of 35
Urologic Oncology
|
February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective study
Emily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.
Oncotarget
|
March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
Markus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Urologic Oncology
|
October 23, 2022
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria
Eva Charlotte Kuckuck, Jörg Hennenlotter, Tilman Todenhöfer, et al.
Urologic Oncology
|
February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer
Natalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
Frontiers in Oncology
|
December 16, 2021
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)
Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, et al.
BJU International
|
January 14, 2010
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
Christian Bolenz, Edwin Herrmann, Patrick J Bastian, et al.
World Journal of Urology
|
August 21, 2012
Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series
Sabine Brookman-May, Matthias May, Vincenzo Ficarra, et al.
International Journal of Surgical Pathology
|
April 25, 2022
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
European Urology
|
January 15, 2010
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study
Giacomo Novara, Kazumasa Matsumoto, Wassim Kassouf, et al.
World Journal of Urology
|
January 21, 2011
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients
Wolfgang Otto, Shahrokh F Shariat, Hans-Martin Fritsche, et al.
Page
of 35